February 27, 2026

United in Care at JADPRO Live 2025

JADPRO Live 2023 showcased groundbreaking collaborations in oncology education and practice, uniting healthcare professionals to enhance cancer care.

JADPRO

February 23, 2026

FDA Approves New Option in Obesity

The Allurion Gastric Balloon System is now authorized by the US Food and Drug Administration for short-term weight loss in adults aged 22 to 65 years with obesity and a body mass index of 30 to 40 kg/m2.

Conexiant

February 17, 2026

FDA Broadens Pitolisant Label

The US Food and Drug Administration approves pitolisant (WAKIX) tablets for the treatment of cataplexy in pediatric patients aged 6 years and older with narcolepsy.

Conexiant

February 13, 2026

What Was Promised at Confirmation?

After pledging to uphold vaccine policy and funding, RFK Jr. has reshaped advisory panels, research priorities, and immunization guidance.

KFF Health News

February 12, 2026

FDA Approves HRT Label Changes

The agency cited updated evidence in revising hormone therapy safety language.

Conexiant

February 10, 2026

Why Scientists Are Revisiting a Polarizer

The nation’s top cancer institute takes a closer look at a disputed drug.

KFF Health News

February 09, 2026

The Assignment Some Doctors Refused

Forced deployments to immigration detention are pushing US public health clinicians to resign—and raising urgent questions about medical ethics, obedience, and harm.

KFF Health News

January 30, 2026

Hospitals, Custody, and the Missing Patient

As detained patients enter hospitals, access to care, communication, and advocacy becomes unclear.

KFF Health News

January 28, 2026

When Crisis Calls Go Unanswered

Behind the promise of 988, response breakdowns reveal risks for patients in acute distress.

KFF Health News

January 27, 2026

The Exam Room Is Listening Now

As AI quietly enters exam rooms, physicians report real relief—and real concerns about accuracy, trust, and control.

KFF Health News